These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31719570)

  • 1. Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β
    Sencanski M; Glisic S; Šnajder M; Veljkovic N; Poklar Ulrih N; Mavri J; Vrecl M
    Sci Rep; 2019 Nov; 9(1):16555. PubMed ID: 31719570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β
    Sencanski M; Glisic S; Kubale V; Cotman M; Mavri J; Vrecl M
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β
    Martin C; Moors SLC; Danielsen M; Betti C; Fabris C; Sejer Pedersen D; Pardon E; Peyressatre M; Fehér K; Martins JC; Mosolff Mathiesen J; Morris MC; Devoogdt N; Caveliers V; De Proft F; Steyaert J; Ballet S
    Chemistry; 2017 Jul; 23(40):9632-9640. PubMed ID: 28449310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
    Plazinska A; Kolinski M; Wainer IW; Jozwiak K
    J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.
    Staus DP; Wingler LM; Strachan RT; Rasmussen SG; Pardon E; Ahn S; Steyaert J; Kobilka BK; Lefkowitz RJ
    Mol Pharmacol; 2014 Mar; 85(3):472-81. PubMed ID: 24319111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
    Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
    Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective binding of agonists to the β
    Plazinska A; Plazinski W
    Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of porcine beta1- and beta2-adrenergic receptors in heart, skeletal muscle, and adipose tissue, and the identification of an atypical beta-adrenergic binding site.
    Sillence MN; Hooper J; Zhou GH; Liu Q; Munn KJ
    J Anim Sci; 2005 Oct; 83(10):2339-48. PubMed ID: 16160045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α
    Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
    Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
    Plazinska A; Plazinski W; Jozwiak K
    J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.
    Mandić M; Drinovec L; Glisic S; Veljkovic N; Nøhr J; Vrecl M
    PLoS One; 2014; 9(11):e112664. PubMed ID: 25401701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations.
    Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X
    PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity of antibodies at the bovine beta2-adrenoceptor.
    Hill RA; Hoey AJ; Sillence MN
    J Anim Sci; 1998 Jun; 76(6):1651-61. PubMed ID: 9655586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-binding affinity of alternative conformers of human β
    Dilcan G; Doruker P; Akten ED
    Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of linker length and composition on heterobivalent ligand-mediated receptor cross-talk between the A1 adenosine and β2 adrenergic receptors.
    Barlow N; Baker SP; Scammells PJ
    ChemMedChem; 2013 Dec; 8(12):2036-46. PubMed ID: 24106065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
    Plazinska A; Plazinski W; Jozwiak K
    Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
    Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A
    Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor.
    Chakir K; Xiang Y; Yang D; Zhang SJ; Cheng H; Kobilka BK; Xiao RP
    Mol Pharmacol; 2003 Nov; 64(5):1048-58. PubMed ID: 14573753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.